This consultation sought your views on whether to bring all nicotine containing products (NCPs) – with the exception of tobacco and tobacco products - within the medicines licensing regime. This would require all currently unlicensed NCPs on the market, such as electronic cigarettes containing nicotine and nicotine gels, to apply to the MHRA for a medicines marketing authorisation (MA).
Responses from key public health-focused organisations
Royal College of Physicians
(87Kb)
Royal College of General Practitioners (55Kb)
British Medical Association (59Kb)
Royal Pharmaceutical Society (55Kb)
ASH (224Kb)
UK Centre for Tobacco Control Studies (89Kb)
British Heart Foundation (229Kb)
Trading Standards Institute (439Kb)
LACORS (201Kb)
Copies of all the replies, excluding those marked 'in confidence' are below.
To find a specific response, look for the number in brackets after the resonse in the tables (eg individual (1)) in the replies below.
| Public | ||
|---|---|---|
|
Yes to option 1 – regulate and remove from the market within 21 days
|
||
|
Yes to option 2 – regulate with 1 year (or longer) to comply
|
||
| Yes to some form of regulation/tighter control but do not remove from the market | ||
|
|
|
|
Regulate no comment on timing
|
||
|
No comment
|
||
| No definitive views on regulation | ||
|
|
|
| Yes to option 3 – take no action | ||
|
|
|
| Medical professional bodies including pharmacy, royal colleges, public health and NHS bodies | ||
|---|---|---|
|
Yes to option 1 – regulate and remove from the market within 21 days
|
||
|
Yes to option 2 – regulate with 1 year (or longer) to comply
|
||
|
Yes to some form of regulation/tighter control but do not remove from the market
|
||
|
Regulate no comment on timing
|
||
|
No comment
|
| Local authorities and trading standards | ||
|---|---|---|
|
Yes to option 1 – regulate and remove from the market within 21 days
|
||
|
Yes to option 2 – regulate with 1 year (or longer) to comply
|
| Manufacturers/importers/retailers and tobacco industry | ||
|---|---|---|
|
Yes to option 1 – regulate and remove from the market within 21 days
|
||
|
Yes to option 2 – regulate with 1 year (or longer) to comply
|
||
|
Yes to some form of regulation/tighter control but do not remove from the market
|
||
|
Regulate no comment on timing
|
||
|
No definitive views on regulation
|
||
Yes to option 3 - take no action
|
| Pharmaceutical industry/healthcare industry | ||
|---|---|---|
|
Yes to option 1 – regulate and remove from the market within 21 days
|
||
|
Yes to option 2 – regulate with 1 year (or longer) to comply
|
||
Yes to option 3 - take no action
|
Download documents:
-
Outcome of consultation exercise MLX364 on the regulation of nicotine containing products (NCPs) (98Kb)
-
Draft scope of programme of research (24Kb)
-
Nicotine containing products – questions and answers (31Kb)
-
Report of qualitative research findings (1610Kb)
-
Public consultation (MLX 364): The regulation of nicotine containing products (220Kb)
-
MHRA Public Assessment Report - The use of nicotine replacement therapy to reduce harm in smokers (65Kb)
-
Extracts from the minutes of the Expert Working Group on nicotine replacement therapy (NRT) (56Kb)
-
Extracts from the minutes of the Commission on Human Medicines - Oct 09 (24Kb)
-
Drug Safety Update February 2010 - Nicotine replacement therapy and harm reduction (25Kb)
